NCT00969163View on ClinicalTrials.gov

A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

June 30, 2005

Conditions
Skin Androgenization
Interventions
DRUG

testosterone gel

300 ug or 2.5 mg transdermal testosterone gel daily for 6 weeks

DRUG

Comparator: placebo

transdermal placebo gel for 6 weeks

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00969163 - A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED). | Biotech Hunter | Biotech Hunter